Domenico Fanara

This inventor holds 17 USPTO granted patents and 9 published patent applications, plus 8 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Ucb S.a., Ucb Pharma, S.a., Ucb Farchim Sa. Active years: 2001-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Domenico Fanara. Retrieved from https://idiyas.com/inventor/domenico-fanara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 9)

% Patents Active = 88.2

CIPO Patents = 8

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 344(Granted Patents)

Location History:

Wanze, BE (2001 - 2015)
Brussels, BE (2013 - 2020)

Company Filing History:

Years Active: 2001-2020

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Prolonged Release

2-Oxo-1-Pyrrolidine

Brivaracetam

Gellable Compositions

Controlled Release

Piperazine Derivatives

Cyclodextrin

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10729653 - Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives (2020-08-04),

2. 10172805 - Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivative (2019-01-08),

3. 8946229 - Formulations (2015-02-03),

4. 8633194 - Pharmaceutical composition of piperazine derivatives (2014-01-21),

5. 8563036 - Pharmaceutical compositions comprising Brivaracetam (2013-10-22),

6. 8460712 - Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate (2013-06-11),

7. 8435564 - Pharmaceutical compositions comprising brivaracetam (2013-05-07),

8. 7226614 - Tablet comprising cetirizine and pseudoephedrine (2007-06-05),

9. 7083807 - Pharmaceutical compositions for the controlled release of active substances (2006-08-01),

10. 7014867 - Tablet comprising cetirizine and pseudoephedrine (2006-03-21),

11. 6818224 - Use of gellable pharmaceutical compositions in periodontology (2004-11-16),

12. 6699502 - Pharmaceutical compositions for controlled release of active substances (2004-03-02),

13. 6471970 - Use of pharmaceutical compositions capable of being gelled in periodontology (2002-10-29),

14. 6464987 - Pharmaceutical compositions capable of being gelled (2002-10-15),

15. 6455533 - Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin (2002-09-24),

Title: **Domenico Fanara: Innovator in Pharmaceutical Compositions**

Introduction

Domenico Fanara, an accomplished inventor located in Wanze, Belgium, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 17 patents, his innovations focus primarily on the development of novel pharmaceutical formulations that enhance the efficacy of treatment options available today.

Latest Patents

Among his latest inventions are two noteworthy patents that push the boundaries of pharmaceutical science. The first is a patent for "Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives," which relates to an immediate release formulation of pharmaceutical compounds. The second patent details "Prolonged release formulations comprising a 2-oxo-1-pyrrolidine derivative," specifically innovating a pharmaceutical composition that utilizes Levetiracetam, Brivaracetam, or Seletracetam as the active ingredient, focusing on a sustained release formulation.

Career Highlights

Throughout his career, Domenico has been associated with prestigious companies such as UCB S.A. and UCB Pharma S.A., which are renowned for their commitment to pharmaceutical excellence. His role in these organizations has facilitated the advancement of his research and development endeavors, further establishing him as a key figure in the industry.

Collaborations

Domenico has collaborated with several notable colleagues, including Monique Berwaer and Michel Deleers. These collaborations have enriched his research and contributed to the successful innovation of new pharmaceutical products that address various medical needs.

Conclusion

In summary, Domenico Fanara stands out as a prominent inventor in the pharmaceutical field, leveraging his expertise to create impactful compositions that promise to enhance patient care. With 17 patents to his name and ongoing contributions to pharmaceutical science, his work continues to inspire future innovations and sets a standard for excellence in the industry.

Profile summary based on public USPTO records.